ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 1 filers reported holding ACCELERON PHARMA INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $74,176,000 | +35.1% | 431,009 | -1.5% | 0.19% | +35.5% |
Q2 2021 | $54,919,000 | -9.9% | 437,633 | -2.6% | 0.14% | -19.4% |
Q1 2021 | $60,941,000 | +3.7% | 449,383 | -2.2% | 0.18% | +10.8% |
Q4 2020 | $58,783,000 | +14.5% | 459,453 | +0.7% | 0.16% | +3.9% |
Q3 2020 | $51,318,000 | +90.3% | 456,037 | +61.1% | 0.15% | +67.0% |
Q2 2020 | $26,961,000 | +1017.3% | 282,998 | +954.3% | 0.09% | +810.0% |
Q1 2020 | $2,413,000 | +64.3% | 26,842 | -3.1% | 0.01% | +100.0% |
Q4 2019 | $1,469,000 | +30.9% | 27,709 | -2.5% | 0.01% | +25.0% |
Q3 2019 | $1,122,000 | -15.4% | 28,412 | -12.0% | 0.00% | -20.0% |
Q2 2019 | $1,326,000 | -16.0% | 32,281 | -4.7% | 0.01% | -16.7% |
Q1 2019 | $1,578,000 | -25.7% | 33,870 | -30.6% | 0.01% | -40.0% |
Q4 2018 | $2,125,000 | – | 48,785 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Novo Holdings A/S | 1,103,937 | $53,563,000 | 5.39% |
GREAT POINT PARTNERS LLC | 758,000 | $36,778,000 | 5.10% |
Foresite Capital Management II, LLC | 244,756 | $11,876,000 | 4.18% |
GREAT POINT PARTNERS LLC | 552,300 | $26,798,000 | 3.71% |
Foresite Capital Management III, LLC | 278,753 | $13,525,000 | 2.91% |
QVT Financial LP | 190,977 | $9,266,000 | 2.66% |
Perceptive Advisors | 1,528,205 | $74,149,000 | 1.94% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,126,800 | $54,672,000 | 1.92% |
SECTORAL ASSET MANAGEMENT INC | 306,626 | $14,877,000 | 1.66% |
Parametrica Management Ltd | 5,645 | $274,000 | 1.30% |